JPRN-UMIN000035625已完成未知
Efficacy and safety of sofosbuvir/belpatasvir combination tablets for patients infected with pan-genotypic hepatitis C virus - Sofosbuvir/velpatasvir therapy for patients with HCV
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who do not have consent to clinical research 2) Patietns accompanying HCC 2) Patients with pregnancy
研究者
相似试验
招募中
Unknown
Efficacy and Safety of sofosbuvir/velpatasvir for HCV infected patients with decompensated LCJPRN-UMIN000050343Hokkaido University Hospital50
招募中
不适用
Evaluation of the efficacy of sofosbuvir/velpatasvir and ribavirin in Japanese hepatitis C patients who failed direct-acting antiviral agents: a prospective study in real life settings.cirrhotic and non cirrhotic patients with hepatitis C virusJPRN-UMIN000035713Toranomon Hospital150
招募中
2 期
Efficacy and safety of Sofosbuvir in the treatment of SARS-CoV-2: An Open Label phase II TrialSARS-CoV-2 ?associated SARI.SARS-CoV-2U07.1IRCT20200328046882N1Shahid Beheshti University of Medical Sciences60
招募中
2 期
Efficacy & Safety of Sofosbuvir/Daclatasvir treatment in COVID-19: A randomized, controlled studyCOVID-19SARS-nCoV-2 infectionDRKS00022203PHARCO CORPORATE90
招募中
不适用
Evaluation of the efficacy of sofosbuvir and velpatasvir in HCV-infected Japanese patients with decompensated cirrhosis: a prospective study in real life settings.decompensated cirrhotic patients with hepatitis C virusJPRN-UMIN000035711Toranomon Hospital100